Fuso Teiyaku (Qingdao) Co., Ltd., as the subsidiary corporation invested by Japan Teikoku Seiyaku Group in China, has completely introduced Teikoku Seiyaku Group half a century of advanced transdermal technology and strict quality management system, with the production of high quality medical supplies in line with the demands of the Chinese market and with high precision technology as the tenet, aiming to create the first brand of transdermal absorption technology in China.

As China has become the more and more important market in the world, as the new strength in the world economy, the positive and far-reaching influence of China to the world economy is becoming increasingly obvious. With Fuso Teiyaku further development in China, Chinese business of Fuso Teiyaku has also begun to be integrated into the globalization sales system of Teikoku Seiyaku Group. Fuso Teiyaku (Qingdao) Co., Ltd. will make use of Teikoku Seiyaku Group research,& development, production, sales and service network all over the world, rooted in the Chinese market, focused on the goal of "Create the first brand of transdermal absorption technology in China" to provide consumers with more and more advanced products with human nature, and continue to pay attention to and support the development of Chinese medicine business, committed to become the outstanding enterprise citizen, hand in hand together with the Chinese society, to create beautiful future.

Fuso Teiyaku (Qingdao) Co.,Ltd.
General Manager: KASAI MIKIYA